Planta Med 2013; 79(02): 97-101
DOI: 10.1055/s-0032-1328102
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Fetal and Neonatal Outcomes in Women Reporting Ingestion of Licorice (Glycyrrhiza uralensis) during Pregnancy[*]

June-Seek Choi
1   Korean Motherisk Program, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
,
Jung-Yeol Han
1   Korean Motherisk Program, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
,
Hyun-Kyong Ahn
1   Korean Motherisk Program, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
,
Hyun-Mee Ryu
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
,
Moon-Young Kim
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
,
Jin-Hoon Chung
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Cheil General Hospital & Womenʼs Healthcare Centre, Kwandong University School of Medicine, Seoul, Republic of Korea
,
Alejandro A. Nava-Ocampo
3   PharmaReasons – Pharmacological Research & Applied Solutions, Toronto, Ontario, Canada
4   Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
5   Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada
,
Gideon Koren
4   Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
5   Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada
6   The Motherisk Program, Hospital for Sick Children, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

received 25 May 2012
revised 25 October 2012

accepted 03 December 2012

Publication Date:
08 January 2013 (online)

Abstract

Maternal intake of licorice from dietary sources has been associated with adverse maternal and fetal outcomes. We prospectively studied the outcome of 185 singleton pregnancies who took over-the-counter or naturopathic formulations containing licorice during their pregnancy, and 370 age-matched singleton pregnant controls that were not exposed to any potential teratogen. The indication in 56.8 % of the women taking licorice was for cough and cold control, with the maximum dose of 2104 mg/day and exposure occurring between the 4th day and 25th week of gestation. The rate of stillbirths was marginally higher among women who took licorice than those who did not (OR = 7.9; 95 % CI 0.9–71.5; p = 0.048), and significantly higher when compared to the general population in the Republic of Korea (OR = 13.3; 95 % CI 4.9–35.8; p < 0.001). Other fetal outcomes assessed in the study were similar between the two study groups, e.g., the OR of major malformations was 3.9 (95 % CI 0.4–43.5; p = 0.27). In conclusion, the present study suggests that licorice is not a major teratogen. However, whether licorice may increase the risk of stillbirths requires careful consideration in further studies with a larger sample size.

* This study was presented as a poster at the 2012 Annual Meeting of the Organization of Teratology Information Specialists; Baltimore, MD, USA, June 22–26, 2012.


 
  • References

  • 1 Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008; 22: 709-724
  • 2 Shin SH, Cho DH, Jang JY, Baek IJ, Yon JM, Nam SY, Yun YW, Kim YB, Kim SS, Rhee GS, Kwack SJ. Effects of licorice on embryonic and fetal development in rats. J Toxicol Pub Health 2005; 21: 325-332
  • 3 Cuzzolin L, Francini-Pesenti F, Verlato G, Joppi M, Baldelli P, Benoni G. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiol Drug Saf 2010; 19: 1151-1158
  • 4 Strandberg TE, Järvenpää AL, Vanhanen H, McKeigue PM. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol 2001; 153: 1085-1088
  • 5 Räikkönen K, Pesonen AK, Heinonen K, Lahti J, Komsi N, Eriksson JG, Seckl JR, Järvenpää AL, Strandberg TE. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am J Epidemiol 2009; 170: 1137-1146
  • 6 Räikkönen K, Seckl JR, Heinonen K, Pyhälä R, Feldt K, Jones A, Pesonen AK, Phillips DI, Lahti J, Järvenpää AL, Eriksson JG, Matthews KA, Strandberg TE, Kajantie E. Maternal prenatal licorice consumption alters hypothalamic-pituitary-adrenocortical axis function in children. Psychoneuroendocrinology 2010; 35: 1587-1593
  • 7 World Medical Association. WMA Declaration of Helsinki – Ethical principles for medical research involving human subjects. 59th WMA General Assembly, Seoul, Korea, October 2008. Available at http://www.wma.net/en/30publications/10policies/b3/index.html Accessed October 24, 2012
  • 8 World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification system. Norwegian Institute of Public Health. Oslo, Norway. Available at http://www.whocc.no/atc/structure_and_principles/ Accessed October 24, 2012
  • 9 Strandberg TE, Andersson S, Järvenpää AL, McKeigue PM. Preterm birth and licorice consumption during pregnancy. Am J Epidemiol 2002; 156: 803-805
  • 10 World Health Organization. Neonatal and perinatal mortality: country, regional and global estimates. Available at. http://whqlibdoc.who.int/publications/2006/9241563206_eng.pdf Accessed October 24, 2012
  • 11 Kamei J, Nakamura R, Ichiki H, Kubo M. Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol 2003; 469: 159-163
  • 12 Kamei J, Saitoh A, Asano T, Nakamura R, Ichiki H, Iiduka A, Kubo M. Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol 2005; 507: 163-168
  • 13 Fukai T, Satoh K, Nomura T, Sakagami H. Antinephritis and radical scavenging activity of prenylflavonoids. Fitoterapia 2003; 74: 720-724
  • 14 Fukai T, Satoh K, Nomura T, Sakagami H. Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra . Fitoterapia 2003; 74: 624-629
  • 15 Niwa K, Hashimoto M, Morishita S, Yokoyama Y, Mori H, Tamaya T. Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice. Jpn J Cancer Res 1999; 90: 726-732
  • 16 Sigurjónsdóttir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens 2001; 15: 549-552
  • 17 Sigurjonsdottir HA, Manhem K, Axelson M, Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens 2003; 17: 125-131
  • 18 Bradley P. British herbal compendium, Volume 2. A handbook of scientific information on widely used plant drugs. Surrey: BHMA Publishing; 2006
  • 19 McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Products Associationʼs botanical safety handbook. Boca Raton: CRC Press LLC; 1997
  • 20 Park D, Yang YH, Choi EK, Yang G, Bae DK, Lee SH, Kim TK, Kyung J, Kim D, Choi KC, Kim YB. Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA. Birth Defects Res B 2011; 92: 553-559
  • 21 U.S. National Library of Medicine and the National Institutes of Health. MedlinePlus. Licorice: copyrighted, evidence-based medicine resource provided by Natural Medicines Comprehensive Database Consumer Version (last reviewed – 07/13/2011). Available at http://www.nlm.nih.gov/medlineplus/druginfo/natural/881.html Accessed October 24, 2012